Další formáty:
BibTeX
LaTeX
RIS
@proceedings{2210977,
author = {Kauerová, Tereza and Onuščáková, Magdaléna and Bobáľ, Pavel and Kollár, Peter},
booktitle = {70. česko-slovenské farmakologické dny},
doi = {http://dx.doi.org/10.2478/afpuc-2022-0009},
keywords = {histone deacetylase inhibitors – vorinostat – hydroxamic acids – proliferation – apoptosis},
language = {eng},
title = {Study of Biological Activity of Novel Hydroxamic Acids Derived From Vorinostat as the Inhibitor of Histone Deacetylases},
url = {https://sciendo.com/issue/afpuc/69/s1},
year = {2022}
}
TY - CONF
ID - 2210977
AU - Kauerová, Tereza - Onuščáková, Magdaléna - Bobáľ, Pavel - Kollár, Peter
PY - 2022
TI - Study of Biological Activity of Novel Hydroxamic Acids Derived From Vorinostat as the Inhibitor of Histone Deacetylases
KW - histone deacetylase inhibitors – vorinostat – hydroxamic acids – proliferation – apoptosis
UR - https://sciendo.com/issue/afpuc/69/s1
N2 - Histone deacetylase inhibitors (iHDACs), a class of epigenetic regulators, are substances with anticancer activity that is associated with inhibition of cell proliferation, induction of programmed cell death, inhibition of angiogenesis, and induction of the cytodifferentiation process in cancer cells. Hydroxamic acid derivatives are currently the most important group of iHDACs. Our study was focused on the evaluation of biological activity of new hydroxamic acids derivates as potential iHDACs designed and synthesised by the Department of Chemical Drugs in Faculty of Pharmacy at Masaryk University.
ER -
KAUEROVÁ, Tereza, Magdaléna ONUŠČÁKOVÁ, Pavel BOBÁĽ a Peter KOLLÁR. Study of Biological Activity of Novel Hydroxamic Acids Derived From Vorinostat as the Inhibitor of Histone Deacetylases. In \textit{70. česko-slovenské farmakologické dny}. 2022. ISSN~2453-6725. Dostupné z: https://dx.doi.org/10.2478/afpuc-2022-0009.
|
